Can neurostimulation prevent the risk of Alzheimer's disease in elderly individuals with schizophrenia?
- PMID: 24065929
- PMCID: PMC3776154
- DOI: 10.3389/fpsyt.2013.00111
Can neurostimulation prevent the risk of Alzheimer's disease in elderly individuals with schizophrenia?
Keywords: amyloid markers; antipsychotic medications; beta secretase; neuroprotection; neurostimulation; tau pathology.
References
-
- Gazdag G, Ungvari G. Non-pharmacological biological therapies in schizophrenia. Neuropsychopharmacol Hung (2011) 4:233–8 - PubMed
-
- Bernstein HG, Ernst TS, Lendeckel H, Steiner J, Bogerts B. What protects patients with schizophrenia to develop Alzheimer's pathology. In: Ritsner M. editor. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. New York: Springer; (2010). p. 49–61
-
- Davidson M, Harvey PD, Powchik P, Parrella M, White L, Knobler HY, et al. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry (1995) 2:197–207 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources